Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-21-001840
Filing Date
2021-02-16
Accepted
2021-02-16 13:03:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 d210210sc13g.htm SC 13G 40519
2 GRAPHIC jdrillick_sig.jpg GRAPHIC 3335
  Complete submission text file 0001214659-21-001840.txt   46927
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85798 | Film No.: 21635313
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016
Business Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016 212-601-9786
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

EIN.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G